Kristofer Morton is a seasoned professional with over 11 years of experience in the biopharma and biotech sectors, currently serving as the Director of Business Development at Curia. In this pivotal role, Kristofer is instrumental in supporting clients through the complex landscape of large molecule...
Kristofer Morton is a seasoned professional with over 11 years of experience in the biopharma and biotech sectors, currently serving as the Director of Business Development at Curia. In this pivotal role, Kristofer is instrumental in supporting clients through the complex landscape of large molecule and RNA-based therapeutic development. His extensive background in Contract Development and Manufacturing Organizations (CDMOs) enables him to interface effectively with a diverse clientele, ranging from large pharmaceutical companies to innovative biotech startups.
At Curia, Kristofer leads both technical and commercial teams, fostering an environment of collaboration and transparency. His approach is characterized by candor and realistic expectations, which are essential in navigating the often ambiguous challenges of drug development and manufacturing. Kristofer’s expertise in FDA GMP and cGMP manufacturing ensures that all processes meet stringent regulatory standards, while his skills in validation, change control, and quality control are critical in maintaining the integrity of the products being developed.
Key projects under his leadership include the optimization of manufacturing processes for RNA-based therapeutics, where he has successfully implemented strategies that enhance efficiency and reduce time-to-market. Additionally, Kristofer is adept at utilizing tools like Trackwise for quality management, ensuring that all aspects of production adhere to Good Distribution Practices (GDP) and cleaning validation protocols. His ability to solve complex problems and drive innovative solutions positions him as a trusted partner for Curia’s clients, helping them achieve their therapeutic goals with reliability and confidence.
